Simplex Trading’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-800
| Closed | -$3.14K | – | 10294 |
|
|
2025
Q4 | $3.14K | Buy |
+800
| New | +$3.54K | ﹤0.01% | 7668 |
|
|
2025
Q3 | – | Sell |
-900
| Closed | -$2K | – | 10189 |
|
|
2025
Q2 | $2K | Buy |
+900
| New | +$2.9K | ﹤0.01% | 8225 |
|
|
2025
Q1 | – | Sell |
-9,700
| Closed | -$54K | – | 9809 |
|
|
2024
Q4 | $54K | Buy |
9,700
+3,500
| +56% | +$22.6K | ﹤0.01% | 5802 |
|
|
2024
Q3 | $36K | Sell |
6,200
-1,600
| -21% | -$11.6K | ﹤0.01% | 6199 |
|
|
2024
Q2 | $61K | Buy |
7,800
+500
| +7% | +$4.19K | ﹤0.01% | 5879 |
|
|
2024
Q1 | $67K | Buy |
7,300
+6,400
| +711% | +$54K | ﹤0.01% | 5993 |
|
|
2023
Q4 | $7K | Sell |
900
-19,700
| -96% | -$143K | ﹤0.01% | 7703 |
|
|
2023
Q3 | $159K | Buy |
20,600
+11,300
| +122% | +$103K | ﹤0.01% | 4609 |
|
|
2023
Q2 | $106K | Sell |
9,300
-24,000
| -72% | -$248K | ﹤0.01% | 5016 |
|
|
2023
Q1 | $256K | Buy |
33,300
+28,900
| +657% | +$230K | ﹤0.01% | 4026 |
|
|
2022
Q4 | $26K | Buy |
4,400
+500
| +13% | +$2.84K | ﹤0.01% | 6624 |
|
|
2022
Q3 | $23K | Buy |
3,900
+500
| +15% | +$3.2K | ﹤0.01% | 7387 |
|
|
2022
Q2 | $20K | Sell |
3,400
-7,900
| -70% | -$53.4K | ﹤0.01% | 7636 |
|
|
2022
Q1 | $86K | Buy |
11,300
+5,200
| +85% | +$23.2K | ﹤0.01% | 6368 |
|
|
2021
Q4 | $16K | Buy |
6,100
+4,400
| +259% | +$15K | ﹤0.01% | 8629 |
|
|
2021
Q3 | $6K | Hold |
1,700
| – | – | ﹤0.01% | 9233 |
|
|
2021
Q2 | $7K | Buy |
1,700
+1,640
| +2,733% | +$7.43K | ﹤0.01% | 9313 |
|
|
2021
Q1 | $28K | Buy |
+60
| New | +$409 | ﹤0.01% | 7196 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | -$12K | – | 8614 |
|
|
2020
Q2 | $12K | Hold |
10
| – | – | ﹤0.01% | 6564 |
|
|
2020
Q1 | $9K | Hold |
10
| – | – | ﹤0.01% | 6557 |
|
|
2019
Q4 | $13K | Sell |
10
-1
| -9% | -$15 | ﹤0.01% | 6255 |
|
|
2019
Q3 | $18K | Buy |
+11
| New | +$231 | ﹤0.01% | 5903 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$1K | – | 7868 |
|
|
2019
Q1 | $1K | Buy |
+1
| New | +$13 | ﹤0.01% | 6944 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | -$9K | – | 7909 |
|
|
2018
Q3 | $9K | Sell |
5
-5
| -50% | -$96 | ﹤0.01% | 6489 |
|
|
2018
Q2 | $19K | Sell |
10
-45
| -82% | -$889 | ﹤0.01% | 5914 |
|
|
2018
Q1 | $2K | Sell |
55
-93
| -63% | -$2.01K | ﹤0.01% | 5365 |
|
|
2017
Q4 | $64K | Buy |
+148
| New | +$2.54K | ﹤0.01% | 2205 |
|
Other funds holding VYGR
AC
VPC
VCM
OM
EAM
Simplex Trading's VYGR Position: Q1 2026 in Review
Simplex Trading increased its Voyager Therapeutics (VYGR) stake by 174% in Q1 2026, buying an estimated $55.6K and bringing the position to 22,261 shares worth $85.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5271.
Simplex Trading first reported a position in VYGR in Q3 2017 and has held it in 25 quarters since. The position peaked at $650K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.
- Simplex Trading held 22,261 shares of Voyager Therapeutics worth $85.9K as of Q1 2026.
- Simplex Trading bought 14,126 Voyager Therapeutics shares in Q1 2026, an estimated $55.6K.
- Voyager Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5271 holding.
- Simplex Trading first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 25 quarters since.
- Simplex Trading's Voyager Therapeutics position peaked at $650K in Q2 2019.
- 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.